Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery

Launched by JEWISH GENERAL HOSPITAL · Jan 10, 2022

Keywords

ClinConnect Summary

This clinical trial is studying whether giving a special drink called Maltodextrin before heart surgery can help improve heart function in patients who have a weakened heart. Specifically, it focuses on people who are going to have coronary artery bypass grafting surgery and have a lower than normal heart pumping ability. The trial is not yet recruiting participants, but it aims to include adults aged 18 and older who meet specific health criteria. To be eligible, participants must be scheduled for surgery and have a heart condition that makes their heart pump less than 50% efficiently.

If you choose to participate, you will be part of a study where neither you nor your doctors will know if you are receiving the Maltodextrin drink or a placebo (a drink that looks the same but has no active ingredients). This helps ensure that the results are fair and unbiased. It’s important to know that certain health conditions, like difficulty swallowing or certain types of diabetes, may prevent you from being eligible for this trial. Overall, this study aims to better understand how preoperative nutrition can affect recovery and heart function in patients undergoing heart surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 years of age or older
• • Presenting for coronary artery bypass grafting surgery
• • Preoperative left ventricular ejection fraction \< 50%
• • First case of the day (7:30am start time)
• Exclusion Criteria:
• • Dysphagia, gastroparesis
• • Cannot tolerate oral intake
• • Celiac disease
• • Type 1 diabetes